Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1α/PDK4 pathway

Mol Cell Endocrinol. 2020 Aug 20:514:110878. doi: 10.1016/j.mce.2020.110878. Epub 2020 May 25.

Abstract

Atherosclerotic plaque rupture followed by luminal thrombosis is recognized as the main cause of acute cardiovascular events, especially in patients with diabetes. Although previous studies identified stimulation of macrophages polarization with advanced glycation end products (AGEs) results in the rapid progression of atherosclerosis, the underlying mechanisms are not understood fully. The purpose of this study was to investigate the effect of hypoxia-inducible factor-1α (HIF-1α) and pyruvate dehydrogenase kinase 4 (PDK4), critical proteins for regulating glucose metabolism, on macrophages polarization in diabetic atherosclerosis, and relevant mechanisms involved. We found that there is an increased number of M1 macrophages in carotid atherosclerotic tissues of diabetic mice and in AGE-bovine serum albumin (BSA)-treated RAW264.7 cells. Furthermore, we observed that HIF-1α was upregulated in AGE-BSA-induced M1 polarization and that the HIF-1α knockdown reduced macrophage polarization to M1 phenotype caused by AGE-BSA via regulation of PDK4. Thus, our study identified the critical role of HIF-1α/PDK4 axis in AGE-BSA-induced M1 polarization, which reflected the potential association between energy metabolism and inflammation in macrophages.

Keywords: Advanced glycation end products (AGEs); Atherosclerosis; HIF-1α; Macrophage polarization; PDK4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Polarity / drug effects
  • Cell Polarity / immunology
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / pathology
  • Glycation End Products, Advanced / metabolism
  • Glycation End Products, Advanced / pharmacology*
  • HEK293 Cells
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Macrophage Activation / drug effects
  • Macrophages / drug effects*
  • Macrophages / physiology
  • Male
  • Mice
  • Mice, Knockout
  • Phenotype
  • Protein Kinases / metabolism
  • RAW 264.7 Cells
  • Signal Transduction / drug effects

Substances

  • Glycation End Products, Advanced
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Protein Kinases
  • pyruvate dehydrogenase kinase 4